Literature DB >> 21121378

Nanotechnology and nanomaterials: toxicology, risk assessment, and regulations.

Anna M Fan1, George Alexeeff.   

Abstract

Nanomaterials have very unique chemical and physical properties that suggest potential health hazards, but limited health and safety information exists for engineered nanomaterials. This review identifies a need for expanding efforts for addressing health and safety concerns in nanotechnology development and in nanotoxicology of engineered nanomaterials. The efforts include research to generate data for safety evaluation, toxicologic evaluation of potential human health effects, risk assessment to support risk-management decision-making, and regulations development to protect human health and the environment. The federal government's current understanding is that existing statutory authorities are adequate to address oversight of nanotechnology and its applications. On the other hand, the present review identifies weaknesses in the current research efforts and inadequacies in existing regulations. A collaborative effort involving multidisciplinary groups is a key element to address the related needs and issues. While federal agencies with regulatory responsibilities are looked upon to develop and implement sound policies and regulations to protect public health and the environment, state agencies may be required to initiate policies which rapidly incorporate new innovations and address public concerns. To address current and futures need related to nanotechnology, the responsible state agencies need to fill the information gaps and address the health and environmental issues. In California, activities have been initiated, but legislative authority and resources are required to provide risk assessment and health protection in an efficient and timely manner.

Entities:  

Mesh:

Year:  2010        PMID: 21121378     DOI: 10.1166/jnn.2010.2493

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  6 in total

Review 1.  Potential applications and human biosafety of nanomaterials used in nanomedicine.

Authors:  Hong Su; Yafei Wang; Yuanliang Gu; Linda Bowman; Jinshun Zhao; Min Ding
Journal:  J Appl Toxicol       Date:  2017-06-06       Impact factor: 3.446

2.  Subcellular Behaviour Evaluation of Nanopharmaceuticals with Aggregation-Induced Emission Molecules.

Authors:  Xiangdong Xue; Jing Xu; Paul C Wang; Xing-Jie Liang
Journal:  J Mater Chem C Mater       Date:  2016-01-27       Impact factor: 7.393

3.  Immunomodulation and T helper TH₁/TH₂ response polarization by CeO₂ and TiO₂ nanoparticles.

Authors:  Brian C Schanen; Soumen Das; Christopher M Reilly; William L Warren; William T Self; Sudipta Seal; Donald R Drake
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

4.  Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs.

Authors:  Jinhyang Choi; Eunjung Ko; Hye-Kyung Chung; Jae Hee Lee; Eun Jin Ju; Hyun Kyung Lim; Intae Park; Kab-Sig Kim; Joo-Hwan Lee; Woo-Chan Son; Jung Shin Lee; Joohee Jung; Seong-Yun Jeong; Si Yeol Song; Eun Kyung Choi
Journal:  Int J Nanomedicine       Date:  2015-09-29

Review 5.  Nanomedicine applications in orthopedic medicine: state of the art.

Authors:  Mozhdeh Mazaheri; Niloofar Eslahi; Farideh Ordikhani; Elnaz Tamjid; Abdolreza Simchi
Journal:  Int J Nanomedicine       Date:  2015-09-28

Review 6.  Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.

Authors:  Bruno Fonseca-Santos; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2015-08-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.